As investors attempt to identify the COVID-19 vaccine stock that will beat all the others, biotech has become one of the hottest sectors, with the S&P Biotech SPDR ETF having jumped nearly 80% since hitting its March low. Today’s article offers an analysis of three specific biotech stocks and insights on what to do with each if you are considering buying them or already own them. Which of the three do the contributors believe is a buy, and which two do they recommend selling? CLICK HERE.
1 Buy, 2 Sells From One Of The Hottest Sectors
Tags:BiotechBiotech InvestingBiotech SPDR ETFBiotech StocksbuyingCOVID-19COVID-19 Vaccine StockInvestingMarch LowsMarket ConditionsS&P 500sellingstocks